Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Air pollution and cause-specific mortality in EU: a review integrating meta-analysis and meta-regression.

Scientific reports·2026
Same author

An Ex Vivo Model of Post Infectious Bronchiolitis Obliterans in Children Using Reconstituted Human Bronchial Epithelium.

Biomolecules·2026
Same author

Obesity, Air Pollution, and Epigenetic Modifications as Risk Factors for Asthma Phenotypes.

International journal of molecular sciences·2026
Same author

Predicting Clinical Response to Benralizumab Using CT Imaging: Prognostic BenraliScan Study.

Chest·2026
Same author

Adipokines in Obese Asthma: A Complex Relationship Influenced More by Sex, Weight, and Oral Steroid Treatment Than Disease Severity.

Allergy·2026
Same author

Hyaluronan-cholesterol core-shell glycerosomes: innovative nanocarriers for mitigating smoke-induced oxidative stress and inflammation in the lungs.

International journal of pharmaceutics·2026

Related Experiment Video

Updated: Jun 22, 2026

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
05:45

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

Leptin and leptin receptor expression in asthma.

Andreina Bruno1, Elisabetta Pace, Pascal Chanez

  • 1Istituto di Biomedicina e Immunologia Molecolare, Consiglio Nazionale delle Ricerche, Palermo, Italy. andreina@neomedia.it

The Journal of Allergy and Clinical Immunology
|June 23, 2009
PubMed
Summary

Reduced leptin and leptin receptor expression in bronchial epithelium is linked to asthma severity and airway remodeling. This suggests leptin's role in asthma pathogenesis and potential therapeutic targets.

More Related Videos

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Related Experiment Videos

Last Updated: Jun 22, 2026

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing
05:45

Experimental Approach to Examine Leptin Signaling in the Carotid Bodies and its Effects on Control of Breathing

Published on: October 25, 2019

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
13:45

Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin

Published on: December 23, 2010

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Immunology

Background:

  • Leptin, an adipokine, may regulate bronchial epithelial homeostasis.
  • Asthma involves airway remodeling, potentially impacting disease severity.
  • Transforming growth factor-beta (TGF-beta) dysregulation is linked to airway remodeling.

Purpose of the Study:

  • To investigate if bronchial epithelial leptin/leptin receptor pathway dysfunction contributes to asthma pathogenesis and severity.
  • To explore the role of leptin in airway remodeling processes.

Main Methods:

  • In vitro analysis of leptin/leptin receptor expression on human bronchial epithelial cells.
  • Assessing the impact of TGF-beta and fluticasone propionate on leptin receptor expression.
  • Evaluating leptin's effect on TGF-beta release and cell proliferation.
  • Ex vivo analysis of leptin/leptin receptor and airway remodeling markers in asthma patients and healthy controls.

Main Results:

  • Human bronchial epithelial cells express leptin and its receptor in vitro.
  • TGF-beta downregulated, while fluticasone propionate upregulated leptin receptor expression.
  • Leptin reduced TGF-beta release and enhanced cell proliferation.
  • Asthma patients, particularly those with severe disease, exhibited decreased leptin/leptin receptor expression, increased reticular basement membrane thickness, and altered TGF-beta expression compared to healthy controls.

Conclusions:

  • Diminished leptin/leptin receptor expression is a hallmark of severe asthma.
  • Reduced leptin signaling is associated with airway remodeling features in asthma.